STEPHEN MARO, III: Open Payments
NPI 1447762703 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,404 in 56 payments from 13 companies in 2025. Trend: 2023 $1,958 · 2024 $1,783 · 2025 $1,404
Food & beverage: $1,404
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 10 | $308 |
| Collegium Pharmaceutical, Inc. | 15 | $189 |
| BIOTRONIK NRO, Inc. | 2 | $146 |
| MML US, Inc. | 6 | $131 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $129 |
| Abbott Laboratories | 6 | $125 |
| Medtronic, Inc. | 5 | $98 |
| Averitas Pharma Inc. | 3 | $79 |
| Boston Scientific Corporation | 2 | $79 |
| TerSera Therapeutics LLC | 2 | $56 |
Products named: Senza, Prospera, Belbuca, ReActiv8, PROCLAIM, QUTENZA, SYNCHROMEDII, Prialt.
Industry payments across VA — which companies pay providers there.
